EVE — Evolva Holding Income Statement
0.000.00%
Last trade - 00:00
- CH₣6.82m
- CH₣0.99m
- CH₣4.16m
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11.6 | 7.54 | 9.88 | 0.673 | 4.16 |
Cost of Revenue | |||||
Gross Profit | 5.29 | -2.24 | -9.31 | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 31.7 | 32.4 | 51.9 | 1.4 | 104 |
Operating Profit | -20.1 | -24.9 | -42 | -0.724 | -100 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -21.6 | -29.9 | -41.4 | -82.9 | -101 |
Provision for Income Taxes | |||||
Net Income After Taxes | -21.6 | -29.9 | -41.3 | -82.9 | -101 |
Net Income Before Extraordinary Items | |||||
Net Income | -21.6 | -29.9 | -41.3 | -82.9 | -101 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21.6 | -29.9 | -41.3 | -82.9 | -101 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -7.02 | -9.49 | -9.95 | -18.6 | -0.099 |
Dividends per Share |